Identitet

Cefazedone Impurity 9

Nije navedeno · C17H21N5O6S3

01Identitet

Lazychem IDLC-46170
CAS RNNije navedeno
PubChem CID11363784
Molecular formulaC17H21N5O6S3
Molecular weight487.6 g/mol
IUPAC name(6R,7R)-7-[[(5R)-5-amino-5-carboxypentanoyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChIKeyIETFJIRUHZRGGV-GLXFQSAKSA-N

02Struktura i stereokemija

Two-dimensional chemical structure of Cefazedone Impurity 9
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 3 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres3
Ring count3
Secondary amines0
Tertiary amines0
SMILESCC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CCC[C@H](C(=O)O)N)SC2)C(=O)O
InChINije navedeno

03Stereochemistry

The published structure contains 3 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres3Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 8Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status u Indiji

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nazivi i povezanosti

API i matični lijek

Nije navedeno

Nazivi i povezanosti

    06Izvori